Delving into the Latest Updates on Chengdu Shibeikang Biomedical Technology Co Ltd with Synapse

Overview

Tags

Cardiovascular Diseases

Nervous System Diseases

Immune System Diseases

Small molecule drug

Herbal medicine

Chemical drugs

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	3
Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	7
Herbal medicine	1
Chemical drugs	1

Top 5 Target	Count

KCNK(Potassium two pore domain channel subfamily K)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

2

Preclinical

IND Application

1

2

IND Approval

Phase 1 Clinical

2

1

Phase 3 Clinical

NDA/BLA

2

4

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

SBK-002	Ischemic stroke More	NDA/BLA
SHLV Syrup	-	NDA/BLA
SBK012	Cardiovascular Diseases More	Phase 3
Butylphthalide ( KCNK )	Acute Ischemic Stroke More	Phase 1
SBK007	Acute urticaria More	Phase 1